Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study

An amendment to this paper has been published and can be accessed via the original article.

Source: BMC Psychiatry - December 22, 2020 Category: Psychiatry Authors: Akira Iwanami, Kazuhiko Saito, Masakazu Fujiwara, Daiki Okutsu and Hironobu Ichikawa Tags: Correction Source Type: research